| __timestamp | Gilead Sciences, Inc. | Teva Pharmaceutical Industries Limited |
|---|---|---|
| Wednesday, January 1, 2014 | 24890000000 | 20272000000 |
| Thursday, January 1, 2015 | 32639000000 | 19652000000 |
| Friday, January 1, 2016 | 30390000000 | 21903000000 |
| Sunday, January 1, 2017 | 26107000000 | 22385000000 |
| Monday, January 1, 2018 | 22127000000 | 18854000000 |
| Tuesday, January 1, 2019 | 22449000000 | 16887000000 |
| Wednesday, January 1, 2020 | 24689000000 | 16658000000 |
| Friday, January 1, 2021 | 27305000000 | 15878000000 |
| Saturday, January 1, 2022 | 27281000000 | 14925000000 |
| Sunday, January 1, 2023 | 27116000000 | 15846000000 |
| Monday, January 1, 2024 | 28754000000 | 16544000000 |
Cracking the code
In the competitive landscape of pharmaceuticals, Gilead Sciences, Inc. and Teva Pharmaceutical Industries Limited have been key players over the past decade. From 2014 to 2023, Gilead consistently outperformed Teva in revenue, peaking in 2015 with a 31% higher revenue than Teva. Despite fluctuations, Gilead maintained a steady growth trend, with a notable 10% increase from 2018 to 2023. Meanwhile, Teva faced challenges, witnessing a 22% decline in revenue over the same period. This divergence highlights Gilead's strategic positioning and resilience in the market. As the industry evolves, these insights provide a glimpse into the financial health and strategic direction of these pharmaceutical giants. Stay tuned as we continue to monitor their trajectories in this ever-changing sector.
Breaking Down Revenue Trends: Amgen Inc. vs Gilead Sciences, Inc.
Breaking Down Revenue Trends: Sanofi vs Teva Pharmaceutical Industries Limited
Bristol-Myers Squibb Company and Gilead Sciences, Inc.: A Comprehensive Revenue Analysis
Annual Revenue Comparison: Gilead Sciences, Inc. vs BioMarin Pharmaceutical Inc.
Gilead Sciences, Inc. and Bio-Techne Corporation: A Comprehensive Revenue Analysis
Revenue Insights: Gilead Sciences, Inc. and Dynavax Technologies Corporation Performance Compared
Gilead Sciences, Inc. and Celldex Therapeutics, Inc.: A Comprehensive Revenue Analysis
Revenue Showdown: Gilead Sciences, Inc. vs Galapagos NV
Breaking Down Revenue Trends: Teva Pharmaceutical Industries Limited vs BeiGene, Ltd.
Teva Pharmaceutical Industries Limited vs Pharming Group N.V.: Examining Key Revenue Metrics
Revenue Insights: Teva Pharmaceutical Industries Limited and PTC Therapeutics, Inc. Performance Compared
Who Generates More Revenue? Teva Pharmaceutical Industries Limited or Bausch Health Companies Inc.